not tagged
not tagged
['brca', 'ovarian']
issue with parp inhibitors as maintaince therapy for ovarian cancer. benifit is more with brca mutated than with hrd positive. 55 % still needed further chemotherapy cure only for some ?? #esmo2022 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists